Ligand validation:5FZK

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FZK_EDO_A_1757	72%	75%	0.141	0.964	0.74	0.26	-	-	0	0	100%	1
5FZK_EDO_A_1762	70%	86%	0.129	0.945	0.58	0.15	-	-	0	0	100%	1
5FZK_EDO_A_1764	62%	78%	0.163	0.955	0.59	0.32	-	-	0	0	100%	1
5FZK_EDO_A_1759	43%	72%	0.185	0.91	0.45	0.62	-	-	0	0	100%	1
5FZK_EDO_A_1761	41%	79%	0.105	0.819	0.52	0.34	-	-	0	0	100%	1
5FZK_EDO_A_1758	39%	79%	0.185	0.892	0.53	0.33	-	-	0	0	100%	1
5FZK_EDO_A_1763	21%	86%	0.287	0.9	0.56	0.17	-	-	0	0	100%	1
5FZK_EDO_A_1760	15%	72%	0.331	0.891	0.46	0.6	-	-	0	0	100%	1
5FZK_EDO_A_1765	1%	85%	0.3	0.383	0.52	0.23	-	-	0	0	100%	1
5FZ8_EDO_A_1766	95%	85%	0.079	0.982	0.52	0.24	-	-	0	0	100%	1
5FZF_EDO_A_1765	93%	88%	0.082	0.975	0.54	0.14	-	-	0	0	100%	1
6EK6_EDO_A_810	81%	85%	0.119	0.972	0.68	0.07	-	-	0	0	100%	1
5FYU_EDO_A_1764	76%	87%	0.131	0.968	0.6	0.11	-	-	0	0	100%	1
5FY9_EDO_A_1764	75%	86%	0.146	0.98	0.53	0.19	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.